ReviewJournal of clinical medicine2025
Targeted Therapies Modulating Mesenchymal-Epithelial Transition-Linked Oncogenic Signaling in the Tumor Microenvironment: Comparative Profiling of Capmatinib, Bemcentinib, and Galunisertib.
Piotr Kawczak et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.